EUVIMEDEUVIMED entdecken
LeitlinieStudienprotokollOpen Access · CC BY 4.0

Incorporating Antimicrobial Resistance Considerations in Antimicrobial Evidence‐Based Practice Guidelines: A Protocol for the Development of a Checklist and Multifaceted Appraisal of Existing Guidelines

Sara Ibrahim iD, Mark Loeb, Jessica Bartoszko, Maryam Ghadimi iD, Gordon Guyatt, Benedikt Huttner, Alfonso Iorio, Dominik Mertz iD, Lorenzo Moja, Gabriel Rada, Pilar Ramon-Pardo, Ludovic Reveiz und 3 weitere

Clinical and Public Health Guidelines · 2026-04 · 3 (2)

DOI: 10.1002/gin2.70057 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Clinical and Public Health Guidelines, online erschienen am 29.01.2026. Verfasst von Sara Ibrahim und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Research Methods, Evidence, and Impact McMaster University Hamilton Canada. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Antimicrobial resistance (AMR) is a widely recognized threat to global health, mainly driven by the inappropriate use of antimicrobials. Recommendations from evidence‐based practice guidelines (EBPGs) can promote appropriate antimicrobial use. Currently, no guidance exists for considering AMR in EBPGs. This is the protocol for two studies that aim to (1) develop a checklist of AMR considerations for EBPGs and (2) conduct a case study to evaluate existing EBPGs regarding the extent to which AMR is considered among other methodological assessments.

Methods

Using the Delphi technique, we will consult with individuals from four interest‐holder groups to develop and refine a checklist of AMR considerations for EBPGs. To assess EBPGs, we will search various databases for guidelines on four prioritized syndromes (i.e., community‐acquired pneumonia, urinary tract infection, skin and soft tissue infections and exacerbations of chronic obstructive pulmonary disease). We will screen articles in duplicate and in stages to include EBPGs for the prioritized syndromes and will use piloted data extraction forms to extract characteristics of the EBPGs. For each EBPG, we will evaluate whether AMR was considered (using the developed checklist), its trustworthiness (i.e., methodological quality) (using the modified National Guideline Clearinghouse Extent of Adherence to Trustworthy Standards instrument) and its adaptability (using items from existing adaptability frameworks).

Discussion

This work will develop a checklist of AMR considerations for EBPGs and evaluate a subsequent sample of EBPGs to investigate the extent to which AMR is considered. Furthermore, by conducting a methodological appraisal of trustworthiness and adaptability, this study will contextualize results to promote the uptake and appropriate interpretation of existing guidelines. Thus, these findings will be useful to decision‐makers as well as guideline development groups as they highlight what existing work can be trusted and leveraged while also identifying what limitations and gaps need to be addressed.

Schlagwörter

Stichwörter der Autor:innen

antimicrobial resistancecritical appraisalguideline development

Autor:innen und Institutionen

  • Department of Health Research Methods, Evidence, and Impact McMaster University Hamilton Canada.
  • Department of Pathology & Molecular Medicine McMaster University Hamilton Canada.
  • Department of Medicine McMaster University Hamilton Canada.
  • Antimicrobial Resistance Division World Health Organization Geneva Switzerland.
  • Health Products Policy and Standards World Health Organization Geneva Switzerland.
  • Epistemonikos Foundation Santiago Chile.

ORCID-Profile: Sara Ibrahim, Maryam Ghadimi, Dominik Mertz, Romina Brignardello-Petersen

Förderung

  • Canadian Institutes of Health Research

Zitieren

APA

Ibrahim, S., Loeb, M., Bartoszko, J., Ghadimi, M., Guyatt, G., Huttner, B., Iorio, A., Mertz, D., Moja, L., Rada, G., Ramon-Pardo, P., Reveiz, L., Wright, G., Santesso, N., & Brignardello-Petersen, R. (2026). Incorporating Antimicrobial Resistance Considerations in Antimicrobial Evidence‐Based Practice Guidelines: A Protocol for the Development of a Checklist and Multifaceted Appraisal of Existing Guidelines. Clinical and Public Health Guidelines, 3(2). https://doi.org/10.1002/gin2.70057

Vancouver

Ibrahim S, Loeb M, Bartoszko J, Ghadimi M, Guyatt G, Huttner B, et al. Incorporating Antimicrobial Resistance Considerations in Antimicrobial Evidence‐Based Practice Guidelines: A Protocol for the Development of a Checklist and Multifaceted Appraisal of Existing Guidelines. Clinical and Public Health Guidelines. 2026;3(2). doi:10.1002/gin2.70057

BibTeX
@article{Ibrahim2026,
  author = {Ibrahim, Sara and Loeb, Mark and Bartoszko, Jessica and Ghadimi, Maryam and Guyatt, Gordon and Huttner, Benedikt and Iorio, Alfonso and Mertz, Dominik and Moja, Lorenzo and Rada, Gabriel and Ramon-Pardo, Pilar and Reveiz, Ludovic and Wright, Gerard and Santesso, Nancy and Brignardello-Petersen, Romina},
  title = {Incorporating Antimicrobial Resistance Considerations in Antimicrobial Evidence‐Based Practice Guidelines: A Protocol for the Development of a Checklist and Multifaceted Appraisal of Existing Guidelines},
  journal = {Clinical and Public Health Guidelines},
  year = {2026},
  volume = {3},
  number = {2},
  doi = {10.1002/gin2.70057}
}
Kostenlos starten →